Annex to newsletter regarding the BPTO Resolution 80/2013.
The full list of products considered strategic by Ministry
of Health and neglected diseases is discriminated in
ordinances No. 978/2008 and No. 1284/2010 of Ministry of Healthy and Annex 1 of Resolution 80/2013. I. Pharmaceutical segment 1. Antiviral (including antiretroviral): Atazanavir Darunavir Efavirenz Enfuvirtide Entecavir Lopinavir Raltegravir Ritonavir Tenofovir 2. Related to neglected diseases Liposomal Amphotericin B Meglumine antimoniate Artesunate Benznidazole Clofazimine Chloroquine Dapsone Amphotericin B deoxycholate Ethambutol Ethionamide Isoniazid Mefloquine Nifurtimox Pyrazinamide Praziquantel Primaquine Rifabutin Rifampicin 3. Related to not transmissible chronic disease (Alzheimer) Donepezil
Rivastigmine (Anti-Asthmatics) Budesonide Formoterol (Antiparkinsonian) Cabergoline Entacapone Tolcapone Pramipexole Selegiline (antipsychotics and anticonvulsants) Clozapine Olanzapine Primidone Quetiapine Topiramate Ziprasidone (antirheumatic and anti-inflammatory) Leflunomide
Mesalazine (Immunosuppressive) Everolimus Mycophenolate mofetil Mycophenolate sodium Tacrolimus Sirolimus (osteoporosis) Calcitonin Calcitriol Raloxifene (pulmonary arterial hypertension) Iloprost Sildenafil (other indications) Bromocriptine Sevelamer hydrochloride Statins Glatiramer Riluzole Somatostatin 4. Products obtained by biological routes: (Monoclonal Antibodies) Adalimumab Dasatinib Imatinib Infliximab Nilotinib Rituximab Trastuzumab Others (enzimes) Alpha dornase Glucocerebrosidase Others (hormones) Insulin-like growth factor (IGF-1) Filgrastim Human chorionic gonadotrophin (HCG) and Pregnant mare's serum gonadotropin (PMSG) Goserelin Glucagon Follicle stimulating hormone Insulin Leuprorelin Somatotropin Others (proteins) Etanercept Procoagulant factors Interferons Octreotide Botulinum toxin Others 5. Vaccines and blood products 6. Medicines and supplies for the therapy of disorders resulting from nuclear accidents II. Segment of medical devices and general devices of support health
Category I - Medical Devices 1. Active medical product for diagnosis A) Diagnostic imaging equipment Flexible and Rigid Endoscopy Equipment Ultrasound diagnostic equipment B) Equipment for in vitro and in vivo diagnostics Equipment that directly generates results for in vitro diagnostic 2. Active medical product for therapy A) Dialysis equipment Hemodialysis equipment and accessories, B) Equipment for general therapy Individual hearing aids (hearing aid) 3. Implantable medical Product A) implantable device Cochlear implant with electric generator Pacemaker, defibrillator and Cardioconversor Implantable device/ Material / article Intrauterine device (IUD) Vena cava filter Cochlear implants with mechanical components only Hip and knee prosthesis with porous coating technology applied to its surface Coronary stent 4. Active medical product for physician-hospital support A) refrigerated centrifuge for blood bag B) freezer /ultralow temperature conservative for samples, blood, vaccines C) simulators for diagnostic imaging equipment 5. Non active medical product for physician-hospital support A) bag for collection and storage of human blood B) dialyzers, needles fistulas and thread for hemodialysis C) medical devices used for contraception or to prevent the transmission of sexually transmitted diseases D) Surgical and procedure synthetic gloves 6. Diagnostic products for use in vivo A) diagnostic kits for detection of diseases and supplies for their production AIDS Botulism Dengue Diphtheria Chagas disease West Nile virus Brazilian spotted fever Leprosy Hantavirus Hepatitis Influenza Cutaneous leishmaniasis Visceral leishmaniasis Malaria Tuberculosis Category II – general devices for health support Equipment for testing and evaluation of the safety and
performance of electrical apparatus under the health surveillance regime, according to specifications of the standard series ABNT NBR IEC 60601 Category III – neglected diseases Chagas disease Dengue Schistosomiasis Leprosy Leishmaniosis Malaria Tuberculosis Buruli ulcer Neurocysticercosis Echinococcosis Bouba Fascioliasis Paragonimiasis Filariasis Rabies Helminthiasis and Manifestations resulting from intoxication or poisoning due to poisonous or venomous animals.
FREQUENTLY ASKED PRE-CONCEPTUAL QUESTIONS The following is meant to provide answers to frequently asked questions during the preconceptual period. This information may be useful to you as you undergo fertility treatment. We welcome you to discuss the following issues or any other fertility-related concerns with us. Lifestyle and environment : Certain lifestyle choices and environment
Please read this agreement carefully before you begin using the Software. By using any part of the Software, you accept all the terms and conditions of this agreement. You agree that this agreement is enforceable like any written contract. If you do not agree, you may not use any part of the Software. Swiss Academic Software (“we”) means Swiss Academic Software GmbH, a Swiss limited
Annex to newsletter regarding the BPTO Resolution 
Mesalazine (Immunosuppressive) Everolimus Mycophenolate mofetil Mycophenolate sodium Tacrolimus Sirolimus (osteoporosis) Calcitonin Calcitriol Raloxifene (pulmonary arterial hypertension) Iloprost Sildenafil (other indications) Bromocriptine Sevelamer hydrochloride Statins Glatiramer Riluzole Somatostatin 4. Products obtained by biological routes: (Monoclonal Antibodies) Adalimumab Dasatinib Imatinib Infliximab Nilotinib Rituximab Trastuzumab Others (enzimes) Alpha dornase Glucocerebrosidase Others (hormones) Insulin-like growth factor (IGF-1) Filgrastim Human chorionic gonadotrophin (HCG) and Pregnant mare's serum gonadotropin (PMSG) Goserelin Glucagon Follicle stimulating hormone Insulin Leuprorelin Somatotropin Others (proteins) Etanercept Procoagulant factors Interferons Octreotide Botulinum toxin Others 5. Vaccines and blood products 6. Medicines and supplies for the therapy of disorders resulting from nuclear accidents II. Segment of medical devices and general devices of support health
performance of electrical apparatus under the health surveillance regime, according to specifications of the standard series ABNT NBR IEC 60601 Category III – neglected diseases Chagas disease Dengue Schistosomiasis Leprosy Leishmaniosis Malaria Tuberculosis Buruli ulcer Neurocysticercosis Echinococcosis Bouba Fascioliasis Paragonimiasis Filariasis Rabies Helminthiasis and Manifestations resulting from intoxication or poisoning due to poisonous or venomous animals.